Connect with us

News

Researchers develop artificial intelligence that can identify cancer cells

Published

on

Scientists from Osaka University in Japan have developed artificial intelligence (AI) that can identify different types of cancers based on microscopy images of their cells. The AI was also able to determine whether the cancer cells were resistant to radiation, and further learned the differences between human and animal cancers. Since the accuracy and timeliness of traditional methods of identifying cancer cells are prone to delays and errors, an accurate and automated system for accomplishing this would be beneficial to cancer research and treatment overall. The results of the scientists’ research were published in the December 2018 issue of Cancer Research.

The type of AI developed for the cell identification is called a convolutional neural network (CNN); it’s loosely based on the connectivity patterns used by neurons in the brain and primarily used for classifying images. As described in their publication, the scientists used a training set of 10,000 images each of human cervical cancer cells (ME-180) and mouse squamous cancer cells (NR-S1), e.g., the thin, flat types of cells found on the surface of the skin and thin linings around various organs throughout the body. They also included images of radioresistant clones with the set, and ultimately obtained a 96% accuracy in a 2,000 image test.

Because the types of cells in a single cancerous tumor can vary widely, identifying the specific cells present is important for determining the best treatment. Thus, having a tool to provide this information quickly and accurately could have a significant impact. The Osaka team hopes to expand the types of cancers their AI can identify and ultimately establish a universal system that can identify all cancer cell types.

Microscopic image of skin cancer cells (squamous) in a mouse (blue). | Credit: Catherine and James Galbraith, Oregon Health and Science University, Knight Cancer Institute/NIH, CC BY-NC 2.0.

Using artificial intelligence in the battle against cancer is being explored throughout the world as the number of uses devised expands. In one notable instance, a team of scientists from The Institute of Cancer Research in London and the University of Edinburgh has developed an AI technique called REVOLVER (repeated evolution of cancer) which identifies DNA mutation patterns in cancers to predict the ways they will change in response to treatment. Similar to how bacteria become resistant to antibiotics, so too can cancers become resistant to the drugs used against them. By removing the unpredictability variable in cancer behavior, scientists would be able to stay ahead of the disease’s progress and tailor treatments accordingly.

The collaboration between AI and healthcare overall is growing, not just in cancer research – even Google is making contributions to the field. Fortunately, the agencies regulating developments are also attuned to the changes. Earlier this year at the AcademyHealth 2018 Health Datapalooza, the U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD signaled the agency’s positive position towards the field. “AI holds enormous promise for the future of medicine, and we’re actively developing a new regulatory framework to promote innovation in this space and support the use of AI-based technologies,” he stated at the event. He also referred to the agency’s plans to streamline their regulations and tools to be sufficiently flexible to handle the rapid pace of advancements and “focus on the ways in which real-world data flows.”

Advertisement

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

News

Tesla Cybercab specs revealed: range, curb weight, range ratings, and more

Published

on

(Credit: Teslarati)

Tesla’s Cybercab has taken a significant step toward production with new technical details emerging from 2026 EPA certification documents.

The filings, which include a Certificate of Conformity issued in late May, provide the most comprehensive public look yet at the purpose-built autonomous vehicle designed for high-volume, low-cost ride-hailing operations.

At its core, the Cybercab is a front-wheel-drive electric vehicle powered by a single 163 kW (219 horsepower) AC permanent magnet motor. Despite its modest output, prioritizing efficiency and cost over neck-snapping acceleration, the vehicle boasts a strong power-to-weight ratio thanks to its lightweight curb weight of 3,113 pounds and a GVWR of 3,730 pounds.

It operates on a 326-volt electrical architecture with a compact ~48 kWh lithium-ion battery pack. The standout revelation is the vehicle’s exceptional efficiency, which Tesla has routinely flexed in the past.

Advertisement

EPA lab tests list an equivalent all-electric range of 418 miles combined and 375 miles on the highway. Tesla has previously targeted around 300 miles of real-world range, and analysts expect the final EPA-rated figure to land near 280-300 miles after adjustment factors.

At a certified 165 Wh/mi in earlier testing, the Cybercab is reportedly the most efficient EV ever produced, significantly outperforming vehicles like the Lucid Air Pure.

This efficiency stems from deliberate design choices tailored for robotaxi duty. The two-seater features a highly aerodynamic shape, minimal weight, which is aided by structural battery integration of what are likely 4680 cells, and no steering wheel or pedals in its fully autonomous configuration.

For ride-hailing fleets, where average trips are short, and can be just five or ten miles, the smaller battery enables faster charging cycles, lower material costs, and reduced vehicle price, a key to Tesla’s goal of a ~$30,000 production cost.

Advertisement

Implications for Autonomous Mobility

These specs underscore Tesla’s strategy: maximize utilization and minimize operating expenses. A ~48 kWh pack could support dozens of short rides per charge, with energy costs potentially dropping below 20 cents per mile at scale. Front-wheel drive simplifies manufacturing and maintenance compared to dual-motor AWD setups in passenger Teslas.

The 219 hp motor provides ample performance for urban and highway speeds without excess, addressing questions about why such power is needed in a “slow” autonomous vehicle. Quick merges and hill climbing still matter for safety and passenger comfort.

Production has already begun at Giga Texas, with EPA certification clearing the path for U.S. deployment. While unsupervised Full Self-Driving remains the critical hurdle, these details paint a compelling picture of a vehicle engineered from the ground up for the robotaxi future: affordable to build, cheap to run, and capable of delivering strong range on a fraction of the battery capacity found in today’s EVs.

As Tesla ramps toward volume output, the Cybercab could reshape urban transportation economics.

Advertisement
Continue Reading

News

Tesla Cybercab snags huge regulatory green light that readies it for public roads

Published

on

Credit: Tesla

Tesla Cybercab, the all-electric ride-hailing-geared vehicle void of a steering wheel and pedals, has achieved a significant regulatory milestone. The vehicle has officially secured an EPA Certificate of Conformity for the 2026 Cybercab, classifying it as a battery electric Zero Emission Vehicle (ZEV).

This certification confirms full compliance with federal Clean Air Act emission standards, paving the way for legal sales and operation across the United States.

A Certificate of Conformity (CoC) is a critical document issued by the U.S. Environmental Protection Agency (EPA) to vehicle manufacturers. It certifies that a specific class of vehicles meets all applicable federal emission requirements for the model year.

We have reported on several of them in the past, and it’s a good sign that a vehicle is close to being available to the public.

Advertisement

Every vehicle sold in the U.S. must carry this approval, which covers exhaust emissions, evaporative emissions, and refueling standards. For battery electric vehicles like the Cybercab, it verifies zero tailpipe emissions and compliance with stringent testing protocols. The certificate, issued and effective May 26, 2026, was part of the EPA’s recent bi-weekly upload, detailing the Cybercab’s evaporative/refueling family and exhaust compliance.

It also revealed some other very important information, as the Cybercab’s “Charge Depleting Range” was rated at just over 418 miles. This was for city driving, while the highway range depletion test revealed just over 375 miles of range:

Advertisement

This EPA approval is a foundational step for Tesla’s autonomous ambitions. While emission certification is standard for any new EV, it signals that the Cybercab is progressing through the full federal compliance process.

Tesla has already equipped prototypes with federal compliance stickers affirming adherence to safety, bumper, and theft-prevention standards via self-certification under FMVSS rules. This bypasses the traditional 2,500-vehicle exemption cap that previously constrained low-volume autonomous testing.

Production of the Cybercab ramped up at Giga Texas starting in early 2026, with volume targets aiming for hundreds of units per week and long-term ambitions of millions annually. The two-seater, steer-by-wire vehicle, lacking a steering wheel and pedals, features a sleek, minimalist design optimized for Robotaxi service.

Tesla Cybercab gets crazy change as mass production begins

Advertisement

Priced under $30,000 at unveiling, it promises operating costs as low as $0.20–$0.40 per mile once scaled. Tesla has routinely flexed it as one of the most efficient vehicles of all time.

Regulatory progress extends beyond the EPA. The NHTSA has streamlined approvals for control-free vehicles, benefiting the Cybercab. Tesla operates supervised and unsupervised Robotaxi services in Texas cities like Austin, Dallas, and Houston using its fleet. California recently updated rules for driverless operations, including enforcement mechanisms for violations. Additional state-by-state approvals will be needed for nationwide rollout.

This EPA green light reduces a key barrier, building confidence among regulators, partners, and investors.

It underscores Tesla’s strategy of designing the Cybercab from the ground up for full compliance rather than retrofitting existing platforms. Challenges remain in scaling unsupervised autonomy, mapping approvals, and public acceptance, but the certification marks tangible momentum toward transforming urban mobility.

Advertisement

With prototypes already testing on public roads and production accelerating, the Cybercab edges closer to redefining transportation. Tesla’s integrated approach—combining hardware simplicity, software prowess, and regulatory diligence—positions it uniquely in the robotaxi race.

Continue Reading

News

SpaceX soars with its first launch as a public company, marking a new era

Published

on

Credit: SpaceX

SpaceX executed its first Falcon 9 launch since going public on June 15, a routine yet symbolically powerful Starlink mission from Vandenberg Space Force Base in California.

Liftoff of the Falcon 9 booster B1093, on its 14th flight, occurred at approximately 8:34 a.m. PDT from Space Launch Complex 4E (SLC-4E), deploying 24 Starlink V2 Mini Optimized satellites into low-Earth orbit.

The first stage successfully landed on the droneship “Of Course I Still Love You” in the Pacific Ocean, underscoring the company’s unmatched reusability track record.

This mission comes just three days after SpaceX’s historic IPO on June 12, which shattered records as the largest ever. The company raised $75 billion by pricing shares at $135, with trading under ticker SPCX on Nasdaq opening at $150 and closing at $160.95—a 19 percent gain—valuing SpaceX at over $2.1 trillion.

The launch highlights the seamless transition from private innovator to public powerhouse. SpaceX, founded in 2002, has revolutionized access to space with over 650 Falcon 9 flights and a massive Starlink constellation now serving millions globally.

As a public company, it faces new pressures: quarterly earnings, shareholder scrutiny, and expectations to accelerate Starship development for Mars ambitions and deeper NASA partnerships. Yet the market response signals strong confidence in its dominance, as launch costs are slashed by 95 percent, rapid satellite deployment, and a backlog of government and commercial contracts.

Advertisement

SpaceX maintains bold advertising push for Starlink, contrasting Tesla’s minimalistic approach

Analysts view today’s flight as business as usual, but it carries extra weight. With shares volatile in early trading days, successful operations reassure investors that core capabilities remain unaffected by public status.

SpaceX now operates under heightened transparency, potentially unlocking capital for ambitious goals like Starship orbital tests and global broadband expansion.

Challenges loom, including regulatory hurdles for megaconstellations, competition in reusable rockets, and orbital debris concerns. Nevertheless, this morning’s flawless execution reinforces SpaceX’s trajectory.

Advertisement

As Musk often notes, the company’s mission—to make humanity multiplanetary—now aligns with Wall Street’s growth demands. The stars, it seems, are aligning for both.

Continue Reading